METHOD FOR METABOLIC SYNDROME TREATMENT USING DOPAMINE RECEPTOR AGONISTS Russian patent published in 2017 - IPC A61K31/44 A61P3/10 

Abstract RU 2624232 C2

FIELD: medicine.

SUBSTANCE: central action dopamine agonist is administered. The administration is carried out so as to provide a peak of the dopamine agonist level in the plasma in a time interval between 4.00 and 12.00 pm.

EFFECT: effective treatment of the metabolic syndrome and associated nonmetabolic disorders due to normalization of the circadian rhythm of dopaminergic activity.

12 cl, 12 dwg, 11 ex

Similar patents RU2624232C2

Title Year Author Number
METHOD OF TREATING METABOLIC SYNDROME WITH USING DOPAMINE RECEPTOR AGONISTS 2008
  • Kinkotta Ehntoni Kh.
RU2473344C2
THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES 2008
  • Kinkotta Ehntoni Kh.
RU2467743C2
THE NUTRITIONAL COMPOSITIONS ON THE BASIS OF THE EXTRACT OF TOUTI AND METHODS OF THEIR APPLICATION 2007
  • Folk Ehnn
  • Grinberg Norman Alan
  • Kaspar Kala
  • Svanson Zhjuli
  • Rafid Zamzam
  • Miller Kevin Berk
  • Dzhonalagadda Sat'Ja
RU2442602C2
APPLICATION OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES SUCH AS TYPE 2 DIABETES 2010
  • Sjun Na
  • Sja Mintsan'
  • Rolet Dehvid Kh.
  • Petersen Jakob Sten
  • Bedvarsdouttir Toura Brin'Ja
RU2566264C2
USE OF QUARTENARY PYRIDINIUM COMPOUNDS FOR VASOPROTECTION AND/OR HEPATOPROTECTION 2008
  • Gebitskij Ezhi
  • Martsinek Andzhej
  • Khlopitskij Stefan
  • Adamus Jan
RU2477132C2
FOOD PRODUCT FOR DIABETICS 2005
  • Shul'Man Avidor
  • Pelled Dori
  • Kouehn Tsafra
RU2380983C2
APPLICATION OF ANGIOGENIN OR ANGIOGENIN AGONISTS FOR TREATING DISEASES AND DISORDERS 2009
  • Makdonakh Meht'Ju
  • Koks Bendzhamin
  • Tester Angus
  • Khobman Piter
RU2519645C2
ACYLATED GLUCAGON ANALOGUE, USE THEREOF AND METHODS OF PRODUCING 2016
  • Riber, Ditte
  • Tolborg, Yakob Lind
  • Khamprekht, Diter Volfgang
  • Tomas, Leo
RU2735762C2
COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE 2003
  • Olme David Grenvill'
  • Shetti Suraj Shivappa
  • Kh'Juz Tomas Ehduard
RU2336876C2
USE OF UGLANEX AS LIPID, CARBOHYDRATE AND PROTEIN NORMALISING DRUG 2011
  • Mikhalev Vladimir Jur'Evich
RU2461386C1

RU 2 624 232 C2

Authors

Kinkotta Entoni Kh.

Dates

2017-07-03Published

2012-12-14Filed